Innate mechanism of pollen- and cat dander–induced oxidative stress and DNA damage in the airways  Koa Hosoki, MD, PhD, David Redding, MD, Toshiko Itazawa,

Slides:



Advertisements
Similar presentations
Nasal challenge with allergen leads to maxillary sinus inflammation
Advertisements

Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation  Md.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Allergen endotoxins induce T-cell–dependent and non–IgE-mediated nasal hypersensitivity in mice  Naruhito Iwasaki, MD, Kazufumi Matsushita, PhD, Ayumi.
The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic.
Weiguo Chen, PhD, Umasundari Sivaprasad, PhD, Aaron M
Robert J. Snelgrove, PhD, Lisa G
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms 
Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to TH2-type immune responses and airway inflammation  Yuki Nakamura,
Distinct TLR-mediated pathways regulate house dust mite–induced allergic disease in the upper and lower airways  Ji-Hwan Ryu, PhD, Jung-Yeon Yoo, BS,
Innate IL-13–producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity  Jillian L. Barlow, PhD, Agustin Bellosi,
Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation  Md.
Vemuri B. Reddy, PhD, Thomas A
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
Restoration of T-box–containing protein expressed in T cells protects against allergen- induced asthma  Jung Won Park, MD, Hyun Jung Min, MS, Jung Ho Sohn,
Is 9 more than 2 also in allergic airway inflammation?
Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I
Brecht Steelant, PhD, Sven F
Signaling through FcRγ-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses  Melissa Y. Tjota, BA, Cara L. Hrusch, PhD, Kelly.
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Response to sublingual immunotherapy with grass pollen extract: Monotherapy versus combination in a multiallergen extract  Sheila M. Amar, MD, Ronald.
Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis  Carmen Rondón, MD, PhD, Paloma Campo,
Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens  Eric B. Brandt, PhD, Troy A. Scribner, MD, Hiroko.
Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD, PhD, Satoshi Uematsu, MD, PhD, Shizuo Akira,
Bcl2-like protein 12 plays a critical role in development of airway allergy through inducing aberrant TH2 polarization  Zhi-Qiang Liu, MD, PhD, Ying Feng,
A network-based analysis of the late-phase reaction of the skin
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
Peter M. Wolfgram, MD, David B. Allen, MD 
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
Vemuri B. Reddy, PhD, Thomas A
3-Methyl-4-nitrophenol triggers nasal allergy by modulating dendritic cell properties  Xiao-Yu Liu, PhD, Yong-Jin Wu, MD, PhD, Li-Juan Song, MD, Xian-Hai.
Nerve growth factor induces type III collagen production in chronic allergic airway inflammation  Ayşe Kılıç, MSc, Sanchaita Sriwal Sonar, PhD, Ali Oender.
Reply Journal of Allergy and Clinical Immunology
A novel allergen-specific therapy with CD40-silenced B cells and dendritic cells  Motohiko Suzuki, MD, PhD, Makoto Yokota, MD, PhD, Yoshihisa Nakamura,
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
News & Notes Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33–basophil axis in mice  Nicholas Venturelli, BS, Willem S. Lexmond, MD,
MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation  Kristina.
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice  Kyung Sun Lee, PhD, So Ri Kim, MD, PhD, Hee Sun Park, MD, PhD, Seoung.
Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease  Javier Milara, PhD, PharmD,
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity 
Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen  Lucia Gabriele, BS, Giovanna Schiavoni, BS, Fabrizio.
Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase–induced signal by intrapulmonary administration of antioxidants blocks allergic.
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?  Marianne Witten, MD, PhD, Hans-Jørgen Malling, MD, Lars.
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
Subpollen particles: Carriers of allergenic proteins and oxidases
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract  Anil Nanda, MD, Maeve O'Connor, MD,
Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis  Carmen Rondón, MD, PhD, Javier.
Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling  Richard Leigh, MBChB, PhD, Wale.
Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis  Toyoyuki Hanazawa, MD, PhD, Julio.
IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation  Kentaro Takahashi, MD, Koichi.
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity  James N. Francis, PhD, Louisa.
Alvaro A. Cruz, MD, Robert M
Nasal challenge with allergen leads to maxillary sinus inflammation
Eric B. Brandt, PhD, Melissa K. Mingler, MS, Michelle D
Macrolide antibiotics and asthma treatment
Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma  Kyung Sun Lee, PhD, Seoung Ju Park, MD, So Ri Kim, MD,
Dendritic cells in nasal mucosa of subjects with different allergic sensitizations  Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,
The effects of an H3 receptor antagonist (PF ) with fexofenadine on reducing allergic rhinitis symptoms  Jeffrey R. Stokes, MD, Francisco A. Romero,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Attila Kiss, MD, Martin Montes, MD, Sarat Susarla, MD, Elin A
Role of Art v 3 in pollinosis of patients allergic to Pru p 3
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,
TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice  Susumu Nakae, PhD, Carolina Lunderius, PhD,
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Innate mechanism of pollen- and cat dander–induced oxidative stress and DNA damage in the airways  Koa Hosoki, MD, PhD, David Redding, MD, Toshiko Itazawa, MD, PhD, Anirban Chakraborty, PhD, Nisha Tapryal, PhD, Sun Qian, PhD, Huibin Qi, PhD, Leopoldo Aguilera-Aguirre, PhD, Allan R. Brasier, PhD, Veeranki Sreenivas Phani, PhD, Tapas K. Hazra, PhD, Istvan Boldogh, PhD, Sanjiv Sur, MD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 5, Pages 1436-1439.e5 (November 2017) DOI: 10.1016/j.jaci.2017.04.044 Copyright © 2017 Terms and Conditions

Fig 1 TLR4-dependent intracellular ROS generation. A, Many allergenic extracts induce greater ROS generation in TLR4Hi cells compared with TLR4Null cells (n = 6-11 per group). B, Some allergenic extracts and LPS do not induce TLR4-dependent ROS generation (n = 6-11 per group). C, RWPE and CDE induce a greater increase in GSSG in supernatants from TLR4Hi than TLR4Null cells (n = 5 per group). H2DCF-DA, 2′,7′-Dichlorodihydrofluoresceine diacetate. *P < .05, **P < .01, ***P < .001, and ****P < .0001. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 140, 1436-1439.e5DOI: (10.1016/j.jaci.2017.04.044) Copyright © 2017 Terms and Conditions

Fig 2 TLR4-dependent oxidative stress and DNA damage induced by allergenic extracts. A and B, Single challenge with RWPE (Fig 2, A) or CDE (Fig 2, B) induces greater levels of GSSG in BALF of WT than Tlr4 knockout mice. In the WT or TLR4 antioxidant group, N-acetyl cysteine and ascorbic acid was administered 1 hour before RWPE challenge (n = 5-8 per group). C, RWPE induces greater reductions in intracellular antioxidant glutathione (iGSH) levels in TLR4Hi than in TLR4Null cells (n = 5 per group). D, RWPE induces greater mitochondrial ROS generation in TLR4Hi than TLR4Null cells (n = 3-4 per group). E, RWPE induces greater comet tail moments in TLR4Hi than TLR4Null cells (n = 50 per group). F, RWPE induces greater damage in the lung genomic DNA from WT compared with Tlr4 knockout mice (n = 5-6 per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 140, 1436-1439.e5DOI: (10.1016/j.jaci.2017.04.044) Copyright © 2017 Terms and Conditions

Fig E1 Coimmunoprecipitation/western blot analysis. HEK 293 cells stably overexpressing HA-tagged TLR4 but not MD2 (TLR4HA) were transfected with plasmid encoding MD2 to generate TLR4-MD2 expressing cells (TLR4HA-MD2).E6 Stimulation of TLR4Hi-MD2 cells with RWPE induced rapid association of TRAF6 with TLR4 in 10 and 30 minutes. IP, Immunoprecipitation; WB, Western blotting. Journal of Allergy and Clinical Immunology 2017 140, 1436-1439.e5DOI: (10.1016/j.jaci.2017.04.044) Copyright © 2017 Terms and Conditions

Fig E2 RWPE challenge rapidly increases oxidative DNA damage in the noses of allergic human subjects. Intranasal RWPE challenge in human subjects is shown. Patients with allergic rhinitis and positive skin prick test responses to RWPE were challenged with saline on one day and RWPE on another. A, RWPE challenge increased nasal symptom scores for congestion, drainage, and sneezing recorded on subjective scale scores of 0 to 3, yielding a combined total symptom score for all 3 symptoms of a maximum of 9. B, RWPE challenge increased levels of 8-OHdG in nasal fluids 30 minutes after challenge. *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2017 140, 1436-1439.e5DOI: (10.1016/j.jaci.2017.04.044) Copyright © 2017 Terms and Conditions